BEDFORD, Mass., Sep 09, 2010 (BUSINESS WIRE) --

Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced that Charles Sherwood, president and chief executive officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, September 15, 2010 at 9:10 a.m. ET. A live audio webcast of the presentation may be accessed via the "Investors" section of Anika's website at www.anikatherapeutics.com. An archive of the presentation also will be available on the website. At the conference, Dr. Sherwood will discuss the company's business highlights, including progress in the integration of its FAB acquisition.

Online press kit materials are available at: http://www.tradeshownews.com/events/Rodman-Renshaw-Annual-Global-Investment-Conference-NYC/Anika/

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing, repair and regeneration. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika's products range from orthopedic/joint health solutions led by ORTHOVISC®, a treatment for osteoarthritis of the knee; to surgical aids in the ophthalmic and anti-adhesion fields. The company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika's Italian subsidiary, Fidia Advanced Biopolymers, S.r.l (FAB), provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in new areas such as advanced wound treatment and ear, nose and throat care. FAB's regenerative tissue technology advances Anika's vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissue.

SOURCE: Anika Therapeutics, Inc.

Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., 781-457-9000
CEO
or
Kevin W. Quinlan, 781-457-9000
CFO